Weight Loss Success: Semaglutide Turns the Scales on Teen Obesity
Nearly Half of Adolescents Using Semaglutide in Trial Dropped Below the Clinical Cut-Off for Obesity A secondary analysis of the STEP TEENS trial, published in…
The Obesity Society News
Bariatric Surgery: A Weighty Decision With Lifesaving Outcomes
Younger population experiences increased risk of death from suicide and chronic liver disease. A new retrospective study with up to 40 years of follow-up shows…
Weight Loss Medications Could Be Sold for Lower Prices: Semaglutide, Bupropion, Naltrexone, Tirzepatide
Change in cost may improve affordability and access to treatment. New research shows that several anti-obesity medications could be manufactured and profitability sold worldwide…
Weight Loss Medication Shows Promise for People With Diabetes and Obesity
A new study confirms that treatment with Bimagrumab, an antibody that blocks activin type II receptors and stimulates skeletal muscle growth, is safe and effective…
The Obesity Society Issues New Position Statement on COVID-19 Vaccines
Vaccines such as Pfizer, Moderna, Johnson & Johnson and AstraZeneca are designed to prevent severe Coronavirus-19 Disease (COVID-19) due to acute respiratory syndrome coronavirus 2…
Minimal, High-Quality Evidence Dietary Supplements Lead to Weight Loss
Although Americans spend billions of dollars on them, published research shows a lack of strong evidence that dietary supplements and alternative therapies help adults lose…
Obesity Contributes Extra 700 Megatons of Carbon Dioxide Emissions per Year
A new analysis suggests that the increasing average body size of people on Earth, in addition to the growing world population may further challenge attempts…
